author-photo

Hiraku Fukushima

Hokkaido University

43

Papers

186

Citations

Citation Trend

Filter By

Papers (23) Sort By

Journal Conference Others

Aggravation of Pseudomyxoma Peritonei Recognized 31 Months Post Appendectomy: Ono H et al. Aggravation of pseudomyxoma peritonei

2020 Journal of gastroenterology and hepatology research
Show All
- Source
- Cite
- Save
Citations (0)
A Prospective Observational Study on Effect of Short‐Term Periodic Steroid Premedication on Bone Metabolism in Gastrointestinal Cancer (ESPRESSO‐01)

2017 Oncologist
Show All
- Source
- Cite
- Save
Citations (10)
Randomized phase III clinical study comparing postoperative UFT/LV,UFT+LV/UFT and UFT+LV+PSK/UFT+PSK as adjuvant therapy for curatively resected stage III colorectal cancer HGCSG-CAD study.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Study protocol of HGCSG1404 SNOW study: a phase I/II trial of combined chemotherapy of S-1, nab-paclitaxel and oxaliplatin administered biweekly to patients with advanced gastric cancer

2017 BMC Cancer
Show All
- Source
- Cite
- Save
Citations (3)
The efficacy of first-line IRIS with or without bevacizumab in patients with metastatic colorectal cancer: Analysis of two phase II studies.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
230TiPPhase I/II trial of combined chemotherapy of S-1, nab-paclitaxel and oxaliplatin administered biweekly for patients with advanced gastric cancer (HGCSG1404; SNOW study)

2015 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Open‐label, randomized, comparative, phase III study on effects of reducing steroid use in combination with Palonosetron

2015 Cancer Science
Show All
- Source
- Cite
- Save
Citations (28)
Observational cohort study of first-line bevacizumab combined with chemotherapy in metastatic colorectal cancer (HGCSG0802): Comparison of infusional FU/oxaliplatin(OX)+BV and oral FU/OX+BV.

2015 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
157PRandomized controlled trial on the skin toxicity of panitumumab in third line treatment of KRAS Exon2 wild-type mCRC: Japanese Skin Toxicity Evaluation Protocol with Panitumumab: J-STEPP/HGCSG1001: updated analysis of anti-tumor efficacy

2015 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Randomized controlled trial on the skin toxicity of panitumumab in Japanese patients with metastatic colorectal cancer: HGCSG1001 study; J-STEPP

2015 Future Oncology
Show All
- Source
- Cite
- Save
Citations (42)